These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8711945)
1. [In vivo registration of monophasic action potentials--new possible applications in clinical electrophysiology]. Behrens S; Franz MR Z Kardiol; 1996 May; 85(5):326-33. PubMed ID: 8711945 [TBL] [Abstract][Full Text] [Related]
2. [Ventricular tachycardia and ventricular fibrillation. Diagnostic procedure for selection of patients for non-medicamentous therapeutic procedures]. Schmidinger H Wien Med Wochenschr; 1992; 142(15-16):341-6. PubMed ID: 1481538 [TBL] [Abstract][Full Text] [Related]
3. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH; Yee R; Jung W J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [TBL] [Abstract][Full Text] [Related]
4. [Biventicular pacing in patients with severe heart failure]. Merkely B; Vágó H; Bartha E; Zima E; Moravcsik E; Gellér L Orv Hetil; 2001 Dec; 142(51):2835-40. PubMed ID: 11828932 [TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of monophasic action potential registration in long QT syndrome]. Merkely B; Tomcsányi J; Tenczer J; Vecsey T; Gyöngy T; Solti F; Bodor E Orv Hetil; 1996 Feb; 137(6):283-6. PubMed ID: 8714403 [TBL] [Abstract][Full Text] [Related]
7. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions. Zareba W Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515 [No Abstract] [Full Text] [Related]
8. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
9. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current. Cua M; Veltri EP Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):382-6. PubMed ID: 7681187 [TBL] [Abstract][Full Text] [Related]
10. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart. Swartz JF; Jones JL; Fletcher RD Circulation; 1993 Jun; 87(6):1907-14. PubMed ID: 8504503 [TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
12. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. Armoundas AA; Albert CM; Cohen RJ; Mela T; J Cardiovasc Electrophysiol; 2004 May; 15(5):594-7. PubMed ID: 15149432 [TBL] [Abstract][Full Text] [Related]
13. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques. Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253 [TBL] [Abstract][Full Text] [Related]
14. [Catheter ablation of ventricular outflow tract arrhythmias using an electroanatomic mapping system]. Horlitz M; Schley P; Sause A; Müller M; Shin DI; Klein RM; Gülker H Med Klin (Munich); 2005 Oct; 100(10):611-6. PubMed ID: 16220249 [TBL] [Abstract][Full Text] [Related]
15. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [TBL] [Abstract][Full Text] [Related]
16. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
17. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK; Patel JA; Nagra BS; Ledley GS Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367 [TBL] [Abstract][Full Text] [Related]
18. [Clinical value of monophasic action potentials]. Franz MR Z Kardiol; 1991 Apr; 80(4):241-9. PubMed ID: 1862664 [TBL] [Abstract][Full Text] [Related]
19. T-wave alternans, restitution of human action potential duration, and outcome. Narayan SM; Franz MR; Lalani G; Kim J; Sastry A J Am Coll Cardiol; 2007 Dec; 50(25):2385-92. PubMed ID: 18154963 [TBL] [Abstract][Full Text] [Related]
20. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies]. Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]